A group of experts on the frontlines during the COVID-19 pandemic share their experiences and findings to help improve our collective effort during any future similar event that might occur. See what they observed.

See how the use of standing orders can help guide clinicians through complicated vaccination recommendations.

Recent data highlights a worrisome trend in childhood vaccination rates. Check out the findings.

Review the science behind measuring hepatitis B antibody titers and find tips for communicating with patients about the importance of this testing and the process.

Using state-of-the-art technology, researchers say understanding underlying movements and mechanisms may pave the way for more effective forms of CRISPR-based therapy.

Cell phone use was recorded in more than one-third of trips taken by teens in the study sample

On a gorgeous October morning at Lincoln Financial Field, Children’s Hospital of Philadelphia’s (CHOP) 23rd Annual Buddy Walk & Family Fun Day took place benefiting the hospital’s Trisomy 21 (Down syndrome) Program, supporting healthier futures for patients and helping to improve the lives of individuals with Down syndrome. Over the past 22 years, the event has generated $4.6 million and this year, $365,000+ was raised, a record-breaking amount.

Researchers at Children’s Hospital of Philadelphia (CHOP) announced significant findings in the treatment of neuroblastoma, a cancer of the peripheral nervous system that usually occurs as a solid tumor in a child’s chest or abdomen. The study offers insights that could lead to new, personalized medicine approaches in immunotherapy treatment. The findings were published today in the journal Cancer Cell.

The findings show how more rapid results can improve practice and lead to more accurate and timely diagnoses

Alexis A. Thompson, MD, MPH, chief, Division of Hematology, and the Elias Schwartz MD Endowed Chair in Hematology at CHOP, has been recognized for her leadership in sickle cell disease (SCD) treatment and research.